COVID-19 vaccines lead to development of antibodies in patients receiving immunosuppressive therapies for chronic inflammatory diseases (CIDs), according to a small study, providing some reassurance for this patient group. Few side effects were seen and the vaccines did not lead to disease flare-ups. Previous research has found that patients taking more steroids and having high ...
Patients with inflammatory diseases, immunosuppression still mount antibody response to COVID-19 vaccination
By Dave Levitan
12 Apr 2021